Pay in 4 interest-free payments of $6.34 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
A randomized phase II study of nab-paclitaxel + durvalumab + neoantigen vaccine versus nab-paclitaxel + durvalumab in metastatic triple-negative breast cancer (mTNBC)
Excessive deposition of extracellular matrix (ECM) and lung tissue remodelling is a central characteristic of fibrotic disorders and the ECM has been attributed a key role in the progressive nature of IPF 23
Supporting Cellular Repair: Substance abuse can cause significant damage to cells and tissues throughout the body
Busy schedules can push recovery and self-care to the side
US$ 26.04
US$ 26.18
US$ 22.31
,aspect=ignore)
US$ 28.96
US$ 26.94
